Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2020 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
An Overview of 10 Years of Activity of a Molecular Laboratory for Buruli Ulcer Diagnosis at a Field Hospital in Benin.
Fajloun F, Ganlonon L, Gnimavo RS, Sodjinou E, Habib A, Claco E, Agoundoté I, Adeye A, Catraye P, Al-Bayssari C, Moussa EH, Robbe-Saule M, Houezo JG, Kpoton GG, Ayélo AG, Gomez B, Johnson RC, Marsollier L, Marion E, Kempf M. Fajloun F, et al. Among authors: sodjinou e. J Clin Microbiol. 2023 Jun 20;61(6):e0027423. doi: 10.1128/jcm.00274-23. Epub 2023 May 22. J Clin Microbiol. 2023. PMID: 37212702 Free PMC article. Review.
Importance of consultations using mobile teams in the screening and treatment of neglected tropical skin diseases in Benin.
Gnimavo RS, Fajloun F, Al-Bayssari C, Sodjinou E, Habib A, Ganlonon L, Claco E, Agoundoté I, Houngbo OA, Anagonou EG, Biaou CAO, Ayélo AG, Houezo JG, Boccarossa A, Moussa EH, Gomez B, Gine A, Sopoh GE, Marion E, Johnson RC, Kempf M. Gnimavo RS, et al. Among authors: sodjinou e. PLoS Negl Trop Dis. 2023 May 12;17(5):e0011314. doi: 10.1371/journal.pntd.0011314. eCollection 2023 May. PLoS Negl Trop Dis. 2023. PMID: 37172044 Free PMC article.
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Phillips RO, Robert J, Abass KM, Thompson W, Sarfo FS, Wilson T, Sarpong G, Gateau T, Chauty A, Omollo R, Ochieng Otieno M, Egondi TW, Ampadu EO, Agossadou D, Marion E, Ganlonon L, Wansbrough-Jones M, Grosset J, Macdonald JM, Treadwell T, Saunderson P, Paintsil A, Lehman L, Frimpong M, Sarpong NF, Saizonou R, Tiendrebeogo A, Ohene SA, Stienstra Y, Asiedu KB, van der Werf TS; study team. Phillips RO, et al. Lancet. 2020 Apr 18;395(10232):1259-1267. doi: 10.1016/S0140-6736(20)30047-7. Epub 2020 Mar 12. Lancet. 2020. PMID: 32171422 Free PMC article. Clinical Trial.